Pascal M. W. Drake

2.5k total citations · 1 hit paper
37 papers, 1.7k citations indexed

About

Pascal M. W. Drake is a scholar working on Biotechnology, Molecular Biology and Immunology. According to data from OpenAlex, Pascal M. W. Drake has authored 37 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Biotechnology, 30 papers in Molecular Biology and 12 papers in Immunology. Recurrent topics in Pascal M. W. Drake's work include Transgenic Plants and Applications (31 papers), Plant tissue culture and regeneration (24 papers) and CRISPR and Genetic Engineering (12 papers). Pascal M. W. Drake is often cited by papers focused on Transgenic Plants and Applications (31 papers), Plant tissue culture and regeneration (24 papers) and CRISPR and Genetic Engineering (12 papers). Pascal M. W. Drake collaborates with scholars based in United Kingdom, United States and Canada. Pascal M. W. Drake's co-authors include Julian K‐C., Paul Christou, Daniel Chargelegue, Craig J. van Dolleweerd, Patricia Obregón, Nicholas D. Vine, Matthew J. Paul, Alessandra Prada, Lorenzo Frigerio and James M. Nuttall and has published in prestigious journals such as PLoS ONE, Nature Reviews Genetics and The FASEB Journal.

In The Last Decade

Pascal M. W. Drake

37 papers receiving 1.6k citations

Hit Papers

The production of recombinant pharmaceutical proteins in ... 2003 2026 2010 2018 2003 200 400 600

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Pascal M. W. Drake United Kingdom 20 1.4k 1.4k 453 379 128 37 1.7k
Clemens Grünwald‐Gruber Austria 25 1.1k 0.8× 649 0.5× 238 0.5× 387 1.0× 261 2.0× 80 1.6k
Carla Marusic Italy 19 767 0.6× 718 0.5× 422 0.9× 198 0.5× 81 0.6× 32 1.2k
Rachel Chikwamba South Africa 20 979 0.7× 717 0.5× 672 1.5× 157 0.4× 48 0.4× 34 1.5k
Jürgen Drossard Germany 14 1.3k 1.0× 1.3k 0.9× 336 0.7× 313 0.8× 135 1.1× 18 1.5k
Sylvain Marcel United States 15 582 0.4× 511 0.4× 497 1.1× 139 0.4× 53 0.4× 17 1.0k
Andreas Loos Austria 16 497 0.4× 495 0.4× 163 0.4× 221 0.6× 132 1.0× 20 746
Dheeraj Verma United States 14 1.0k 0.7× 649 0.5× 327 0.7× 133 0.4× 19 0.1× 22 1.4k
Kathleen Hefferon United States 21 750 0.5× 467 0.3× 548 1.2× 112 0.3× 28 0.2× 89 1.3k
Laurence Menu‐Bouaouiche France 15 658 0.5× 300 0.2× 402 0.9× 159 0.4× 42 0.3× 21 1.0k
Françoise H. Routier Germany 25 915 0.7× 250 0.2× 457 1.0× 172 0.5× 79 0.6× 55 1.7k

Countries citing papers authored by Pascal M. W. Drake

Since Specialization
Citations

This map shows the geographic impact of Pascal M. W. Drake's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pascal M. W. Drake with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pascal M. W. Drake more than expected).

Fields of papers citing papers by Pascal M. W. Drake

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pascal M. W. Drake. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pascal M. W. Drake. The network helps show where Pascal M. W. Drake may publish in the future.

Co-authorship network of co-authors of Pascal M. W. Drake

This figure shows the co-authorship network connecting the top 25 collaborators of Pascal M. W. Drake. A scholar is included among the top collaborators of Pascal M. W. Drake based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pascal M. W. Drake. Pascal M. W. Drake is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Smith, Samuel Pattillo, et al.. (2023). Characterisation of a Live-Attenuated Rabies Virus Expressing a Secreted scFv for the Treatment of Rabies. Viruses. 15(8). 1674–1674. 3 indexed citations
2.
Reljić, Rajko, et al.. (2020). Rational design and expression of a recombinant plant rhabdovirus glycoprotein for production of immunoreactive murine anti-sera. Protein Expression and Purification. 175. 105691–105691. 2 indexed citations
3.
Dolleweerd, Craig J. van, et al.. (2020). Development of a minigenome cassette for Lettuce necrotic yellows virus: A first step in rescuing a plant cytorhabdovirus. PLoS ONE. 15(3). e0229877–e0229877. 3 indexed citations
4.
Hobbs, Matthew, et al.. (2020). Shotguns vs Lasers: Identifying barriers and facilitators to scaling-up plant molecular farming for high-value health products. PLoS ONE. 15(3). e0229952–e0229952. 13 indexed citations
5.
Paul, Matthew J., Rajko Reljić, Katja Klein, et al.. (2014). Characterization of a plant-produced recombinant human secretory IgA with broad neutralizing activity against HIV. mAbs. 6(6). 1585–1597. 45 indexed citations
6.
Pepponi, Ilaria, Elena Stylianou, Craig J. van Dolleweerd, et al.. (2013). Immune-Complex Mimics as a Molecular Platform for Adjuvant-Free Vaccine Delivery. PLoS ONE. 8(4). e60855–e60855. 19 indexed citations
7.
8.
Paul, Matthew J., et al.. (2011). Antibody degradation in tobacco plants: a predominantly apoplastic process. BMC Biotechnology. 11(1). 128–128. 45 indexed citations
9.
Paul, Matthew J., Craig J. van Dolleweerd, Pascal M. W. Drake, et al.. (2011). Molecular pharming. Human Vaccines. 7(3). 375–382. 29 indexed citations
10.
Irons, Sarah L., et al.. (2010). Expression and plasma membrane localization of the mammalian B‐cell receptor complex in transgenic Nicotiana tabacum. Plant Biotechnology Journal. 9(4). 455–465. 1 indexed citations
11.
Drake, Pascal M. W., et al.. (2010). Generation of transgenic plants expressing plasma membrane-bound antibodies to the environmental pollutant microcystin-LR. Transgenic Research. 20(3). 701–707. 5 indexed citations
12.
Drake, Pascal M. W. & Harry Thangaraj. (2010). Molecular farming, patents and access to medicines. Expert Review of Vaccines. 9(8). 811–819. 11 indexed citations
13.
Colgan, Richard, C. J. Atkinson, Matthew J. Paul, et al.. (2009). Optimisation of contained Nicotiana tabacum cultivation for the production of recombinant protein pharmaceuticals. Transgenic Research. 19(2). 241–256. 29 indexed citations
14.
Obregón, Patricia, Daniel Chargelegue, Pascal M. W. Drake, et al.. (2005). HIV‐1 p24–immunoglobulin fusion molecule: a new strategy for plant‐based protein production. Plant Biotechnology Journal. 4(2). 195–207. 70 indexed citations
15.
K‐C., Julian, Pascal M. W. Drake, Daniel Chargelegue, Patricia Obregón, & Alessandra Prada. (2004). Antibody processing and engineering in plants, and new strategies for vaccine production. Vaccine. 23(15). 1814–1818. 48 indexed citations
16.
K‐C., Julian, Pascal M. W. Drake, & Paul Christou. (2003). The production of recombinant pharmaceutical proteins in plants. Nature Reviews Genetics. 4(10). 794–805. 663 indexed citations breakdown →
17.
Drake, Pascal M. W., et al.. (2003). Rhizosecretion of a monoclonal antibody protein complex from transgenic tobacco roots. Plant Molecular Biology. 52(1). 233–241. 55 indexed citations
18.
Vine, Nicholas D., Pascal M. W. Drake, Andrew Hiatt, & Julian K‐C.. (2001). Assembly and plasma membrane targeting of recombinant immunoglobulin chains in plants with a murine immunoglobulin transmembrane sequence. Plant Molecular Biology. 45(2). 159–168. 17 indexed citations
19.
Chargelegue, Daniel, Patricia Obregón, & Pascal M. W. Drake. (2001). Transgenic plants for vaccine production: expectations and limitations. Trends in Plant Science. 6(11). 495–496. 23 indexed citations
20.
Chargelegue, Daniel, Nicholas D. Vine, Craig J. van Dolleweerd, Pascal M. W. Drake, & Julian K‐C.. (2000). A murine monoclonal antibody produced in transgenic plants with plant-specific glycans is not immunogenic in mice. Transgenic Research. 9(3). 187–194. 93 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026